Pryanka Thakur | Dengue | Young Scientist Award

Published on by Cell Biologist

Dr. Pryanka Thakur | Dengue | Young Scientist Award

Dr. Pryanka Thakur | Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh | India

Dr. Pryanka Thakur is a dedicated virologist and Project Research Scientist-I at PGIMER, Chandigarh, working in Professor Sunil Sethi’s laboratory. She earned her Ph.D. in Virology from PGIMER under the mentorship of Professor (Dr.) Radha Kanta Ratho, Dean of PGIMER. Her research revolves around molecular pathogenesis, particularly focusing on viral diseases such as Dengue, COVID-19, Hepatitis E, and emerging zoonotic threats. With numerous high-impact publications and presentations at national and international forums, Dr. Thakur has built a commendable academic and research portfolio. Her work contributes to a deeper understanding of viral mechanisms and their public health implications. She has received accolades like the Young Scientist Award and DST-SERB travel grant, reflecting her potential as a rising star in infectious disease research. Passionate about molecular diagnostics and disease pathogenesis, Dr. Thakur’s academic rigor and commitment position her as a promising candidate for the Research for Young Scientist Award.

Publication Profile: 

Orcid

Scopus

Education:

Dr. Pryanka Thakur completed her Ph.D. in Virology at the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, from August 2018 to March 2024. Her thesis, titled “Role of inflammasome and autophagy in the pathogenesis of severity of Dengue fever,” was conducted under the supervision of Professor (Dr.) Radha Kanta Ratho, a leading authority in virology. Her doctoral work explored critical host-pathogen interactions, offering insights into mechanisms influencing disease severity. During this period, she honed her skills in molecular virology, diagnostics, and cellular biology. Her academic foundation is deeply rooted in translational and clinical virology, with particular emphasis on autophagy, inflammasomes, and immunological responses during viral infections. Through her rigorous training and extensive hands-on experience with cutting-edge lab techniques, she emerged as a well-rounded scientist with both technical expertise and conceptual depth in infectious disease research, specifically RNA viruses and M. tuberculosis.

Experience:

Dr. Pryanka Thakur currently serves as a Project Research Scientist-I in the Department of Medical Microbiology, PGIMER, Chandigarh, under the mentorship of Professor Sunil Sethi. Her research has primarily focused on virological and immunological responses to emerging and re-emerging infections. She has extensive experience in molecular biology, cell culture, diagnostics, and bioinformatics, contributing to major national and international research initiatives. During her Ph.D., she contributed significantly to studies on Dengue pathogenesis, SARS-CoV-2 evolution, and the intersection of autophagy and inflammasome activity. Her experience also includes collaboration with clinicians, epidemiologists, and diagnostic labs, showcasing her ability to work in interdisciplinary settings. Beyond lab work, she has actively participated in scientific writing, mentoring junior researchers, and presenting findings at forums like ECCMID and VIROCON. Her track record reflects a strong combination of leadership, innovation, and research integrity—making her a standout young investigator.

Awards and Honors:

Dr. Pryanka Thakur’s excellence in research has been recognized through prestigious accolades. In 2024, she was honored with the Young Scientist Award at the VIROCON 2024 conference held at DRDE, Gwalior, for her impactful Ph.D. research on Dengue virus pathogenesis. Additionally, she secured the highly competitive DST-SERB International Travel Grant to present her work at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark. These honors are a testament to the significance and quality of her research in infectious diseases. Her recognition on both national and international platforms demonstrates her rising reputation within the scientific community. These awards not only validate her current achievements but also underscore her potential for future contributions to global health challenges. Her work continues to resonate with experts in virology, public health, and molecular diagnostics—solidifying her status as a promising candidate for further research awards.

Research Focus:

Dr. Pryanka Thakur’s research is rooted in the pathogenesis, immunology, and molecular biology of emerging infectious diseases. Her Ph.D. research dissected the intricate roles of inflammasome activation and autophagy dysregulation in severe Dengue infections—paving the way for targeted therapies and better clinical outcomes. She also actively investigates RNA viruses, including SARS-CoV-2, Hepatitis E, Monkeypox, Nipah, and avian influenza, exploring their mutation patterns, immune evasion strategies, and pandemic potential. Her recent studies also delve into co-infections (e.g., Dengue and COVID-19 in pregnancy), and the reemergence of known pathogens in the post-pandemic era. Dr. Thakur maintains a special interest in molecular diagnostics, enabling early and accurate disease detection. Her contributions bridge laboratory science with clinical relevance, aiming to develop diagnostic tools and deepen our understanding of host-pathogen dynamics. This interdisciplinary approach positions her to make substantial contributions to the field of translational virology and public health microbiology.

Publications Top Notes: 

  1. Waves and variants of SARS-CoV-2: Understanding the causes and effect of the COVID-19 catastrophe – Infection, 2022.

  2. Viral Hepatitis E and Chronicity: A growing public health concern – Frontiers in Microbiology, 2020.

  3. Monkeypox virus in humans: A concern – Trespassing global boundaries – Int J Surg, 2022.

  4. Emergence of novel omicron hybrid variants: BA(x), XE, XD, XF – More than just alphabets – Int J Surg, 2022.

  5. Nipah Outbreak: Beginning of another pandemic in the era of COVID-19 and Zika? – Brain Behav Immun, 2021.

  6. Evolutionary dynamics of emergent SARS-CoV-2 variants: Just within a year – Immunome Research, 2021.

  7. Avian influenza revisited: Concerns and constraints – VirusDisease, 2022.

  8. Maternal and perinatal outcome in Dengue and COVID-19 co-infected pregnancies – Eur J Obstet Gynecol Reprod Biol, 2023.

  9. Post-COVID-19 era: Re-emergence of known and future (X) viral pathogens – Vacunas, 2024.

  10.  Paclitaxel production from endophytic Mucor circinelloides from Himalayan Taxus sp. – 3 Biotech, 2024.

Conclusion:

In conclusion, Dr. Pryanka Thakur is an exceptionally well-qualified candidate for the Research for Young Scientist Award. Her academic rigor, publication excellence, and strong interest in infectious disease pathogenesis make her a standout young researcher. She brings a unique blend of molecular insights and public health relevance to her work, making significant contributions to understanding emerging viral threats. With national recognition and international exposure already under her belt, she is on a clear upward trajectory in academic science. Supporting her at this stage through the Young Scientist Award would not only validate her past contributions but also empower her to lead future advancements in virology, diagnostics, and translational medical research. With minor enhancements in project independence and translational focus, Dr. Thakur is poised to become a future leader in infectious disease research, making her a deserving recipient of this award.

 

John Carethers | DNA Repair | Best Researcher Award

Published on by Cell Biologist

Prof. John Carethers | DNA Repair | Best Researcher Award

Prof. John Carethers, UC San Diego, United States

Dr. John M. Carethers is a distinguished academic leader and physician-scientist in the field of gastroenterology and cancer genetics. Serving as Vice Chancellor for Health Sciences at the University of California San Diego, he also holds professorial appointments in both the School of Medicine and the Herbert Wertheim School of Public Health. His extensive contributions to colorectal cancer research, health disparities, and tumor biology have earned him national recognition. Dr. Carethers is renowned for his work on DNA mismatch repair mechanisms and their implications in cancer progression and treatment responsiveness. With a prolific publication record and influential roles in medicine and science policy, he stands as a model for translational research excellence. His commitment to mentorship and health equity further underscores his holistic impact on the field of medicine. Dr. Carethers continues to push scientific boundaries while advocating for inclusive healthcare solutions.

Publication Profile: 

Google Scholar

Scopus

Education:

Dr. Carethers completed his undergraduate education at Wayne State University, earning a B.S. in Biological Sciences with a minor in Chemistry (1981–1985). He graduated with distinction and was a recipient of the Michigan State Competitive Scholarship. He continued at Wayne State University School of Medicine, where he earned his M.D. with High Distinction in 1989. His academic performance was recognized with multiple honors including the Dean’s Academic Achievement Award and awards from the Black Medical Association. Dr. Carethers then completed an internship in Internal Medicine at Massachusetts General Hospital (1989–1990), a prestigious Harvard-affiliated institution, under the guidance of Chief of Medicine Dr. John T. Potts. His medical and research training provided the foundation for a career focused on gastrointestinal disorders, tumor genetics, and health disparities, particularly in colorectal cancer. His formative years reflect academic excellence and an early commitment to advancing medicine through both practice and research.

Professional Experience:

Dr. John M. Carethers currently serves as the Vice Chancellor for Health Sciences at the University of California San Diego. He is also a Distinguished Professor in the Department of Medicine and an Adjunct Professor in the School of Public Health. His career has spanned prestigious academic roles, including clinical and research leadership in gastroenterology, particularly focused on colorectal cancer. A physician-scientist, Dr. Carethers has served in roles that bridge bench science and clinical application, contributing significantly to translational medicine. His academic journey includes mentorship of emerging scientists, leadership in national research initiatives, and board participation in scientific organizations. His experience also encompasses major roles in cancer health disparities research, aiming to close gaps in outcomes across racial and socioeconomic lines. Dr. Carethers is a prolific researcher and thought leader whose experience enhances institutional vision, diversity, and health equity. His impactful career exemplifies a dedication to excellence in science and medicine.

Awards and Honors:

Dr. Carethers has been recognized with numerous academic and professional honors throughout his career. As an undergraduate, he received the Michigan State Competitive Scholarship and was inducted into the Golden Key National Honor Society. During medical school, he earned the Dean’s Academic Achievement Award and awards from the Black Medical Association in 1986 and 1987. Over time, he has been widely honored for his contributions to colorectal cancer research, healthcare leadership, and advocacy for health equity. His published work has been highly cited and influential in advancing our understanding of tumor genetics and mismatch repair. He has received numerous invitations for keynote talks and appointments to national research boards and committees. Dr. Carethers’s career has been marked by his commitment to mentoring, scholarly productivity, and advocacy, positioning him as a leader and role model in academic medicine. These honors underscore his national and global influence in health sciences.

Research Focus:

Dr. John M. Carethers’s research primarily focuses on colorectal cancer, particularly mechanisms of tumor progression, genetic and epigenetic alterations, and mismatch repair (MMR) deficiency. He has deeply explored how MMR status influences treatment responses, especially to chemotherapy agents like 5-fluorouracil. A key aspect of his work includes identifying biomarkers for cancer prognosis and understanding familial cancer syndromes, including Lynch syndrome and polyposis syndromes. His studies also delve into the molecular mechanisms underlying microsatellite instability (MSI) and its role in genomic instability. Importantly, Dr. Carethers is a leading voice in cancer health disparities, examining how social, economic, and biological factors impact outcomes among underrepresented populations. His research bridges basic molecular science with clinical applications, enabling personalized approaches to treatment and surveillance. Through his work, he contributes to reducing cancer burden and mortality while promoting health equity in vulnerable communities—making him a pioneer in both biomedical research and public health.

Publications Top Notes:

  1.  Experimental and clinical observations on frostbite

  2.  The epidemiology of methicillin-resistant Staphylococcus aureus in a burn center

  3.  Extraintestinal Manifestations of Crohn’s Disease

  4.  Human chromosome 3 corrects mismatch repair deficiency in colon tumor cells

  5.  Delayed gastric emptying after laparoscopic vagotomy

  6.  Mismatch repair and the G2 cell cycle checkpoint

  7. In vitro assay for screening hMLH1 and hMSH2 mutations

  8.  Massive secretory diarrhea and pseudo-obstruction in Crohn’s disease

  9.  Mismatch repair blocks clonal expansion after DNA damage

  10.  Localization of Bannayan-Riley-Ruvalcaba syndrome gene to chromosome 10q23

Conclusion:

In conclusion, Dr. John M. Carethers embodies the highest standards of research excellence, leadership, and societal impact. His contributions to colorectal cancer genetics, DNA mismatch repair research, and cancer health disparities are not only scientifically rigorous but also clinically transformative. As a widely respected physician-scientist, educator, and health equity advocate, he represents the ideal blend of scholarly productivity and service to humanity. Despite minor opportunities for expanding the global and technological dimensions of his work, Dr. Carethers’s achievements place him in the top tier of biomedical researchers. His continued dedication to both advancing science and closing health outcome gaps aligns perfectly with the spirit of the Best Researcher Award. He is not only deserving of this honor but also serves as an inspiring model for current and future generations of researchers.

Xingle Zhao | Gene Therapy of Hearing Loss | Best Researcher Award

Published on by Cell Biologist

Dr. Xingle Zhao | Gene Therapy of Hearing Loss | Best Researcher Award

Dr. Xingle Zhao, The First Affiliated Hospital of Zhengzhou University, China

Dr. Xingle Zhao is a dedicated biomedical researcher with a Ph.D. in Surgery from Shanghai Jiaotong University, focusing on inner ear gene therapy. With a robust academic foundation from Wuhan University and a research journey spanning over a decade, he has contributed significantly to auditory neuroscience. His groundbreaking work in cochlear gene therapy has led to several high-impact publications, including in Nature Communications and Human Gene Therapy. Dr. Zhao’s research centers on advancing therapeutic interventions for hearing loss using adeno-associated virus (AAV)-mediated gene delivery and CRISPR-based editing in murine models. Passionate about translating research into clinical potential, he is recognized for his innovative strategies to restore auditory function. His commitment to excellence and innovation places him as a strong candidate for the Best Researcher Award.

Publication Profile: 

Orcid

 Strengths for the Award:

  1.  Strong Publication Record in High-Impact Journals
    Dr. Zhao has published in top-tier journals such as Nature Communications, Human Gene Therapy, and Molecular Therapy – Methods & Clinical Development. This reflects both the scientific significance and rigor of his work.

  2.  Niche Yet Impactful Research Focus
    His expertise in gene therapy for inner ear disorders is highly specialized and innovative. His work directly contributes to addressing sensorineural hearing loss, a critical unmet medical need.

  3.  Technical Mastery and Innovation
    Dr. Zhao demonstrates advanced skills in using AAV-mediated gene delivery, CRISPR/Cas9, transcriptomic analysis, and base editing—technologies at the forefront of molecular medicine.

  4.  Collaborative Researcher
    He has successfully collaborated with multiple research teams and institutions, showing strong team science orientation, often essential in translational biomedical research.

  5.  Translational Impact
    His research moves beyond basic science to show real therapeutic potential, such as day-one hearing restoration in adult deaf mice using AAV8-mediated Vglut3 rescue—a milestone in preclinical gene therapy.

Areas for Improvement:

  1.  Limited International Exposure
    While his work is high quality, more international collaborations or fellowships could increase his global visibility and broaden the impact of his research.

  2.  Public and Clinical Translation Pathways
    A focus on translating findings into clinical trials, and greater involvement in science communication or patent filings, would enhance the practical application of his discoveries.

  3.  Mentorship and Outreach
    Expanding roles in mentorship, teaching, or scientific leadership could amplify his influence and contribute to academic community-building.

Education:

Dr. Xingle Zhao completed his Ph.D. in Surgery at Shanghai Jiaotong University (2017–2023), where he specialized in gene therapy for inner ear disorders. His doctoral research led to a series of influential publications, pushing forward the understanding and treatment of sensorineural hearing loss through genetic strategies. He focused on AAV vector development, gene editing, and functional restoration in animal models. Prior to his doctoral studies, he earned his Bachelor’s degree in Surgery at Wuhan University (2012–2017). There, he built a solid clinical and anatomical foundation, gaining early exposure to surgical principles and developing core competencies in patient care. His academic training combined cutting-edge biomedical research with real-world medical applications, enabling him to bridge laboratory findings with translational potential. Dr. Zhao’s educational background is rooted in two of China’s leading institutions, reinforcing both his technical rigor and academic integrity.

Experience:

Dr. Xingle Zhao brings a decade of experience in gene therapy and auditory neuroscience. During his Ph.D. at Shanghai Jiaotong University, he led and co-authored multiple studies on cochlear gene editing and therapeutic restoration in mouse models, particularly targeting genes such as Vglut3 and Otoferlin. He has hands-on expertise in AAV vector design, CRISPR-Cas9 technologies, in vivo cochlear injection, and molecular analysis. His role extended from lab-based research to collaborative team science, working with clinicians, molecular biologists, and geneticists across disciplines. Notably, he contributed to a high-impact Nature Communications paper and published in Human Gene Therapy and Hearing Research. Dr. Zhao also demonstrated mentoring capacity with junior researchers and was actively involved in presenting his work at scientific forums. His experience spans preclinical experimentation, data interpretation, and translational strategies, making him highly proficient in targeted gene therapy development for hearing restoration.

Research Focus:

Dr. Xingle Zhao’s research is centered on genetic therapies for hearing loss, with an emphasis on restoring auditory function via gene delivery systems. His work focuses on the development and application of adeno-associated virus (AAV) vectors, CRISPR/Cas9 editing tools, and promoter optimization for inner ear gene targeting. A particular emphasis is placed on rescuing hearing loss in adult and neonatal mouse models, notably targeting genes such as Vglut3 and Otof. His research highlights the potential of rapid gene therapy as a practical intervention in auditory impairment, bridging basic science with potential clinical treatments. Dr. Zhao also investigates the transcriptomic diversity of cochlear genes, uncovering isoform-specific roles in auditory physiology. His vision is to enable safe, efficient, and long-lasting gene therapy protocols that can be translated into future human therapies for sensorineural deafness. This niche yet impactful domain places him at the forefront of auditory gene therapy innovation.

Publication Top Notes: 

  1.  Cochlear transcript diversity and its role in auditory functions implied by an otoferlin short isoform – Nature Communications (2023)

  2.  Gene Therapy Restores Auditory Functions in an Adult Vglut3 Knockout Mouse Model – Human Gene Therapy (2022)

  3.  Characterization of promoters for adeno-associated virus mediated efficient Cas9 activation in adult Cas9 knock-in murine cochleae – Hearing Research (2020)

  4.  Adeno-associated virus vector enables safe and efficient Cas9 activation in neonatal and adult Cas9 knock-in murine cochleae – Gene Therapy (2020)

  5.  Gene editing-based hearing impairment research and therapeutics – Neuroscience Letters (2019)

  6.  A review of application of base editing for the treatment of inner ear disorders – Journal of Bio-X Research (2019)

  7.  Rapid Cochlear Gene Therapy in Adult Deaf Mice: Vglut3 Rescue via AAV8 Achieves Day-1 Hearing Restoration – Molecular Therapy Methods & Clinical Development (2025)

Conclusion:

Dr. Xingle Zhao is a highly suitable candidate for the Best Researcher Award. His impactful work in gene therapy, focused on restoring hearing through precise molecular interventions, represents a significant scientific advancement with strong translational promise. He brings together academic rigor, innovation, and collaboration—hallmarks of a leading biomedical researcher. While expanding global collaboration and clinical engagement could further strengthen his profile, his current contributions already position him as a rising star in auditory genetics and molecular therapeutics.

Subhrajyoti Banerjee | Spinal Cord Injury | Best Researcher Award

Published on by Cell Biologist

Mr. Subhrajyoti Banerjee | Spinal Cord Injury | Best Researcher Award

Mr. Subhrajyoti Banerjee, Griffith University, Australia

Subhrajyoti Banerjee is a dynamic and interdisciplinary biomedical researcher from West Bengal, India, currently pursuing a Ph.D. in Human Biology at Griffith University, Australia. His academic and research trajectory demonstrates a consistent focus on cutting-edge therapeutics, particularly the use of exosome-based techniques in neuroregeneration and brain cancer diagnostics. Subhrajyoti brings a unique blend of molecular biology, bioengineering, and translational medicine to his work, making notable contributions to both diagnostic and therapeutic research. With multiple international peer-reviewed publications, collaborations with hospitals and biotech labs, and hands-on expertise in nanomedicine and immunotherapy, he has established himself as a rising figure in biomedical science. His strong academic record, combined with impactful research in cancer biology and neurological repair, positions him as a promising candidate for significant contributions to global healthcare innovation.

Publication Profile: 

Google Scholar

Orcid

✅ Strengths for the Award:

  1. Interdisciplinary Expertise: Subhrajyoti has deep knowledge in biotechnology, biomedical engineering, and molecular biology, spanning diagnostics, therapeutics, and regenerative medicine.

  2. Cutting-Edge Research: His research on exosomes for brain cancer diagnosis and cell-free therapies using glial extracellular vesicles aligns with global priorities in personalized and non-invasive medicine.

  3. Strong Publication Record: He has multiple peer-reviewed publications, including articles in journals like Extracellular Vesicle, Synlett, and Chemistry – A European Journal.

  4. Hands-on Technical Proficiency: Skilled in molecular biology (PCR, ELISA), bioinformatics (NGS, mutagenesis), nanotechnology, and in-silico drug development.

  5. Academic Excellence: Consistently high CGPAs in all degrees (up to 9.4/10), with top performance in national-level exams like GATE (2020 & 2024).

  6. Early Research Maturity: Significant achievements already at the pre-doctoral and early Ph.D. stage, with collaboration across institutes and real-world applications.

🛠️ Areas for Improvement:

  1. Patent Filing and Commercial Translation: While the research is innovative, translating it into patents, startups, or licensed technologies would amplify real-world impact.

  2. International Collaborations: Though currently pursuing a PhD abroad, broader international co-authorship or research consortium involvement could strengthen global outreach.

  3. Leadership Roles: Opportunities to mentor junior researchers or lead funded projects would further demonstrate leadership potential in the scientific community.

🎓 Education:

Subhrajyoti Banerjee’s academic journey reflects an unwavering commitment to biomedical innovation. He is currently enrolled in a Ph.D. program in Human Biology at Griffith University (2025–Present), focusing on therapeutic applications of olfactory glial extracellular vesicles. He earned his Master of Technology in Biomedical Engineering (2022–2024) from IIEST Shibpur, achieving an outstanding CGPA of 9.4 and conducting research on exosome-based early diagnostics for brain cancer. Prior to this, he completed an M.Sc. in Biotechnology (2018–2020) from Techno India University with a CGPA of 9.01, where he explored antibody mimetics in cancer immunotherapy. His undergraduate studies in Biotechnology (2015–2018) at MAKAUT gave him a strong foundation in genetic engineering, molecular biology, and medical biotechnology. His academic path illustrates both breadth and depth across biomedical disciplines, from basic science to clinical translation.

💼 Professional Experience:

Subhrajyoti’s professional experience is deeply rooted in interdisciplinary biomedical research. As an M.Tech researcher at IIEST (2022–2024), he led projects involving nanoparticle-based theragnostics and collaborated with medical institutions for brain cancer diagnostics. His innovative work involved synthesizing electromagnetic and autofluorescent nanoparticles for tumor detection. Previously, he served as a Research Assistant and Teaching Aid (2019–2020) at Techno India University, where he contributed to cancer immunotherapy studies under Dr. Malavika Bhattacharya. His skills encompass both in-silico and in-vitro techniques, including ELISA, flow cytometry, cell culture, and computational modeling. Additionally, he has coordinated sample collection with hospitals and performed biomarker analysis for exosomal studies. This hands-on lab experience, combined with translational research initiatives, underscores his ability to bridge the gap between laboratory innovation and real-world medical application.

🏅 Awards & Honors:

Subhrajyoti Banerjee has received multiple recognitions highlighting his academic excellence and research potential. He qualified in GATE 2024 and GATE 2020, two of India’s most competitive national-level examinations, affirming his expertise in engineering and life sciences. His work was honored with the 1st Prize for Poster Presentation at the BIRAC 5th Annual Symposium in 2020, reflecting innovation in translational biotech. He also presented at the 4th Regional Science & Technology Congress (2020) and university-level symposia, showcasing his work in both diagnostics and therapeutic biotechnology. These accolades illustrate his proactive engagement with the academic and scientific community. His contributions in nanomedicine, exosome biology, and bioinformatics make him a strong contender for research-based recognitions.

🔬 Research Focus:

Subhrajyoti Banerjee’s research centers on exosome-based diagnostics and therapeutics, with a deep emphasis on brain cancer and neuroregeneration. His ongoing Ph.D. explores olfactory glia-derived extracellular vesicles for cell-free, regenerative therapies. He previously developed liquid biopsy approaches using exosomal biomarkers for early detection of glioblastoma. His expertise spans nanoparticle engineering, molecular docking, antibody mimetics, and cell-line studies, aiming to bridge lab research with clinical solutions. Subhrajyoti’s interdisciplinary approach draws from molecular biology, pharmacology, and bioinformatics, positioning his work at the forefront of personalized medicine and neuro-oncology. His commitment to translational science is evident through multi-institutional collaborations and his ability to apply emerging technologies like NGS, spectroscopy, and computational biology for solving real-world medical problems.

📚 Publications Top Notes:

  1. 🧠 Exploring emerging concepts of exosomes for brain cancer diagnosis and therapeutics – Extracellular Vesicle (2024)

  2. 🏥 Internet of Medical Things and Healthcare 4.0: Trends and future directions – JEEEMI (2024)

  3. ⚗️ Reaction under Ball-Milling: Solvent- and Metal-Free Synthesis of Tetrahydroquinoline Derivatives – Synlett (2024)

  4. 🧪 Room temperature palladium-catalyzed synthesis of unsymmetrical diamide scaffolds – Journal of Molecular Structure (2024)

  5. 🍋 Comparative study of therapeutic properties of lemons – International Journal of Herbal Medicine (2023)

  6. 🔬 Reusable Iron-Copper Catalyzed Cross-Coupling for N-Arylamides – Chemistry – A European Journal (2025)

  7. 💻 Computational Design of Antibody Mimetics for Enhanced Cancer Immunotherapy – Techno India University (2020)

  8. 🧬 Antibody Mimetic for Immunotherapy Against Cancer – University Dissertation (2019)

🔍 Conclusion:

Subhrajyoti Banerjee exhibits all the hallmarks of a rising star in biomedical research: a strong foundation in theory, excellence in lab techniques, impactful research on exosomes and nanomedicine, and a forward-thinking approach to cancer diagnostics and therapeutics.

His ability to navigate between basic science and translational application, and a growing international profile with Griffith University, makes him a highly suitable candidate for the Best Researcher Award. With continued focus on innovation and scientific leadership, he is well-positioned to become a significant contributor to the global biomedical research community.

Song He | Tissue Engineering Regeneration | Best Researcher Award

Published on by Cell Biologist

Dr. Song He | Tissue Engineering Regeneration | Best Researcher Award

Dr. Song He, Hunan University of Humanities, Science and Technology, China

Dr. Song He is a dedicated researcher and lecturer at the School of Energy and Mechanical Engineering, Hunan University of Humanities, Science and Technology. With a strong background in civil materials and energy systems, Dr. He has made impactful contributions in the field of nanoporous aluminum substrates, heat transfer mechanisms, and condensation processes. His research bridges fundamental science and engineering applications, particularly in energy efficiency and materials performance. As a first author on multiple high-impact publications and an inventor on several patents, he has demonstrated both technical depth and innovation. Dr. He’s work is recognized for addressing real-world challenges in sustainable cooling and energy systems. His career path reflects consistent academic growth from undergraduate studies through to a PhD, followed by impactful research and teaching contributions. Passionate about material science and thermal dynamics, Dr. He exemplifies the qualities of a next-generation scientific leader.

Publication  Profile:

Orcid

✅ Strengths for the Award:

  1. Strong Publication Record (First Author & Peer-Reviewed)

    • Multiple first-author journal articles in internationally recognized journals like Materials, Applied Sciences, Energies, and Journal of Materials Research and Technology.

    • Research is focused on high-impact, emerging areas like nanoporous aluminum substrates, solar thermal applications, and frosting mechanisms.

  2. Innovation and Practical Contribution

    • Holder of three patents related to testing devices for heat transfer and solar radiation absorption of aluminum materials, showing real-world application of research.

  3. Specialization in Sustainability and Energy Efficiency

    • Research closely aligns with modern needs for sustainable cities, renewable energy, and climate-adaptive cooling technologies.

    • Topics such as interface condensation, solar absorption, and surface coatings are directly relevant to global energy challenges.

  4. Long-Term Academic and Research Dedication

    • Strong academic background (BEng + PhD) and a consistent career trajectory.

    • Lecturer since 2020, actively involved in both teaching and applied research.

🔧 Areas for Improvement:

  1. Broader International Engagement Needed

    • Limited visibility in international conferences, workshops, and global collaborative projects.

    • Increasing participation in international academic communities would enhance both recognition and impact.

  2. Publication Impact and Journal Tier

    • While the journals are respectable, publishing in top-tier (Q1) journals like Advanced Materials, Nano Energy, or Energy & Environmental Science could elevate the scientific profile.

  3. Postdoctoral or International Fellowships

    • No postdoctoral experience or overseas academic training mentioned.

    • Pursuing a global postdoctoral opportunity would enhance expertise and network.

🎓 Education:

Dr. Song He holds a Ph.D. in Civil Materials and Engineering from Guangdong University of Technology (2015–2020), where his research focused on advanced thermal interface materials and nanoporous substrates. Prior to this, he completed his Bachelor’s degree in Building Environment and Equipment Engineering at Hunan University of Technology (2011–2015), laying the foundation for his interest in energy systems and materials performance. His academic training included interdisciplinary exposure to heat exchange technologies, solar energy applications, and environmental materials, combining theory with hands-on experimentation. Through his doctoral studies, Dr. He developed expertise in micro/nanoporous materials, surface treatments, and condensation properties critical to energy efficiency systems. His strong academic record and progression reflect his commitment to high-impact research and continuous learning. Dr. He’s educational background has prepared him to lead and innovate in the domains of thermal sciences, sustainable technologies, and energy-efficient materials.

💼 Experience:

Since December 2020, Dr. Song He has been a lecturer at the School of Energy and Mechanical Engineering, Hunan University of Humanities, Science and Technology. His teaching and research focus on material science, energy engineering, and surface phenomena. Prior to this, he completed his Ph.D. at Guangdong University of Technology, where he was actively involved in national and regional research projects. Dr. He has collaborated with notable researchers, contributed to interdisciplinary research teams, and co-authored several scientific papers. His hands-on experience includes the development and testing of novel nanoporous aluminum sheets for thermal applications. He has also contributed to the design and patenting of specialized testing devices for thermal and frosting properties. With a blend of academic and experimental work, Dr. He has developed deep knowledge in sustainable materials and surface engineering. His career showcases a balance of scientific inquiry, practical innovation, and educational contribution.

🔬 Research Focus:

Dr. Song He’s research centers on the thermal and surface properties of nanoporous aluminum materials and their applications in energy-efficient systems. His work explores the interface effects, condensation characteristics, solar absorption, and frosting mechanisms of micro/nanostructured materials. A significant part of his research focuses on improving heat exchanger efficiency, air-conditioning performance, and solar thermal energy capture through material innovation. He has studied the role of hygroscopic coatings and nanoporous substrates in enhancing thermal transfer and minimizing frost formation. Dr. He also investigates material-environment interactions, including moisture absorption and radiation management, to support sustainable building technologies. His patented devices offer novel methods for testing aluminum sheets under various environmental conditions. His work bridges fundamental surface physics with real-world energy applications, addressing critical needs in sustainable cities, green energy systems, and advanced thermal technologies. His focus positions him at the intersection of materials innovation and energy efficiency.

📚 Publications Top Notes:

  1. 📘 Investigation of the Interface Characteristics and Frosting Properties of the Nanoporous Alumina Sheets – Journal of Materials Research and Technology, 2025

  2. 🔬 Review of Hygroscopic Coating on Aluminum Fin Surface of Air Conditioning Heat Exchanger – Applied Sciences, 2021

  3. 🌞 Investigation on the Solar Absorption Property of the Nanoporous Alumina Sheet for Solar Application – Materials, 2019

  4. ❄️ Effects and Frosting Mechanism of Nanoporous Alumina Sheets – Energies, 2023

  5. 🧪 Investigation of the Interface Effects and Condensation Properties of the Micro/Nanoporous Aluminum Plates – Sustainable Cities and Society, (Date unspecified)

📌 Conclusion:

Dr. Song He is a highly promising candidate for the Best Researcher Award, especially for his contributions to nanomaterials, surface engineering, and sustainable energy applications. He brings a combination of academic rigor, innovation, and application-driven research that addresses critical energy and environmental challenges.

Herbeuval Jean-Philippe | Immunology Cellular Interactions | Best Innovator Award

Published on by Cell Biologist

Dr. Herbeuval Jean-Philippe | Immunology Cellular Interactions | Best Innovator Award

Dr. Herbeuval Jean-Philippe | CNRS | France

Jean-Philippe Herbeuval is a French immunologist and CNRS Director of Research, renowned for pioneering contributions to translational immunology and biomedical innovation. A PhD holder in immuno-oncology, he completed a prestigious Fogarty Fellowship at the NIH, USA, where he earned the Norman P. Salzman Award. He founded and leads the CBMIT team at Université Paris Cité, integrating immunology, virology, and chemistry for therapeutic discovery. Herbeuval has launched two biotech companies: Ermium Therapeutics, based on anti-interferon therapies, and Elyris Pharma, centered on PDK1 as a novel anti-inflammatory target. With 9 patents (3 licensed), €8.8M in research funding, and >70 publications (h-index 28), his innovations span diagnostics to therapeutics. He also contributes to policy and innovation strategy through national and international committees. Recognized for his vision, leadership, and mentorship, Herbeuval exemplifies the intersection of academic research and impactful biotechnology entrepreneurship.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

  1. Exceptional Innovation in Immunology & Therapeutics

    • Discovered key therapeutic targets such as CXCR4 and PDK1.

    • Founded Ermium Therapeutics (2019) and Elyris Pharma (2024), securing over €12M in funding.

    • Holds 9 patents, with 3 already licensed — a key indicator of translational success.

  2. Proven Scientific Leadership

    • Director of Research (CNRS), Head of CBMIT at Université Paris Cité.

    • Established and led multiple interdisciplinary research teams and platforms (Cyto2BM, CBMIT).

    • Supervised 10 PhD students, 7 postdocs, and over 18 master’s students, many of whom reached elite positions.

  3. High-Impact Research Output

    • 70+ publications, including high-citation studies on interferon signaling in HIV.

    • Over 3,500 citations, h-index: 28 — showing strong impact and visibility.

  4. Strong National and International Recognition

    • Winner of the prestigious i-Lab National Innovation Prize (France, 2019).

    • Invited speaker at over 24 international conferences; reviewer for Nature Medicine and PNAS.

    • Advisor for funding agencies across the US (NIH), UK (MRC), China, and Brazil.

  5. Valuable Public and Government Engagement

    • CNRS Innovation Ambassador (2024) and expert for multiple national programs (ANRS, Campus France).

    • Actively engages in public science communication (TV, radio, press).

🔧 Areas for Improvement:

  1. Scaling Global Industry Impact

    • While Ermium and Elyris are high-potential, further proof of market adoption and therapeutic success will solidify his innovation leadership globally.

  2. Broader Patent Commercialization

    • More patents could potentially be moved from licensing to full-scale clinical trials or product development phases.

  3. Diversity of Therapeutic Areas

    • While the focus on interferon biology and immunomodulation is powerful, broader expansion into other disease domains (e.g., neuroinflammation, metabolic syndromes) could enhance reach.

🎓 Education:

Jean-Philippe Herbeuval earned his PhD in immuno-oncology in 2001 from Université Jean Monnet, Saint-Étienne, working under the INSERM network. He then pursued a highly competitive five-year Fogarty Postdoctoral Fellowship at the National Institutes of Health (NIH), USA, under Dr. Gene Shearer, focusing on the antiviral response to HIV. During this time, he earned multiple prestigious awards including the Norman P. Salzman Award and an NIH Young Scientist Cash Award. Upon returning to France, he secured a CNRS Junior PI position in 2006 and received his Habilitation to Direct Research (HDR) in 2008 from Université Paris Descartes. His rapid career progression continued with his appointment as Director of Research (2nd class) in 2013 and promotion to 1st class in 2019 at CNRS UMR8601. His educational path reflects an exceptional blend of scientific rigor, international exposure, and leadership in innovation.

💼 Experience:

Jean-Philippe Herbeuval brings over two decades of distinguished experience at the interface of academic research and biotech innovation. Starting with his postdoctoral fellowship at NIH (2001–2006), he led groundbreaking studies on interferon responses in HIV. Since 2006, he has served within CNRS, creating and leading the CBMIT interdisciplinary team. He established the Cyto2BM core facility and spearheaded multiple translational projects. As scientific founder of Ermium Therapeutics (2019) and Elyris Pharma (2024, in progress), he has successfully attracted venture capital and secured technology transfer agreements. His strategic involvement extends to national innovation committees (ANRS, CNRS, Campus France) and advisory roles. He has trained over 35 researchers and supervised major national/international grants. Notably, he combines deep scientific insight with an entrepreneurial mindset, as shown by his participation in Deeptech Founders and RISE programs. His experience spans leadership, translational science, investment negotiations, and scientific mentoring.

🔬 Research Focus:

Jean-Philippe Herbeuval’s research is centered on translational immunology, particularly type I interferons, autoinflammatory pathways, and host-pathogen interactions. His work explores immune dysregulation in infectious diseases such as HIV, SARS-CoV-2, dengue, and influenza, with a special focus on the immune-modulatory roles of dendritic cells and apoptotic pathways. He has identified novel therapeutic targets including CXCR4 and PDK1, leading to two biotech start-ups and multiple patents. His interdisciplinary CBMIT team integrates immunology, virology, medicinal chemistry, and computational modeling to develop innovative therapeutic strategies and biomarkers. He has a keen interest in immunomodulation, therapeutic interference with IFN pathways, and discovery of druggable checkpoints in innate immunity. With over 70 peer-reviewed publications, his scientific output has shaped current understanding of immune pathogenesis and opened new avenues for therapy in inflammatory and infectious diseases. His approach bridges fundamental research with practical applications in drug discovery and biotech development.

📚 Publications Top Notes:

  1. 🧬 HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells

  2. ⚰️ CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon–dependent, TRAIL/DR5-mediated apoptosis

  3. 🚻 Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-α production in women

  4. 🧪 HIV-1 immunopathogenesis: how good interferon turns bad

  5. 🔄 Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells

  6. 🧠 Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor vs. nonprogressor HIV-1-infected patients

  7. 🧟 HIV turns plasmacytoid dendritic cells into TRAIL-expressing killer pDC via TLR7-induced IFN-α

  8. 🧬 Regulation of TRAIL on primary CD4+ T cells by HIV-1: role of plasmacytoid dendritic cells

  9. 💉 TRAIL in HIV-1–infected patients and its production by antigen-presenting cells

  10. 🧫 Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6

🧾 Conclusion:

Dr. Jean-Philippe Herbeuval stands out as a highly qualified and deserving candidate for the Best Innovator Award. His rare combination of scientific excellence, translational innovation, entrepreneurial leadership, and mentorship places him in the top tier of biomedical innovators. His work not only bridges science and industry but also directly contributes to addressing global health challenges. Continued support and recognition of his efforts will likely catalyze further innovation in therapeutic immunology.

Salvatore Chirumbolo | Cellular Stress Response | Innovative Research Award

Published on by Cell Biologist

Dr. Salvatore Chirumbolo | Cellular Stress Response | Innovative Research Award

Dr. Salvatore Chirumbolo, Università di Verona, Italy

Dr. Salvatore Chirumbolo is a distinguished Clinical Biochemist and Senior Researcher at the University of Verona, Department of Engineering for Innovation Medicine. He has made pioneering contributions in oxidative stress, immunopharmacology, systems biology, and ozone therapy. Author of over 400 scientific papers and several books, he is among Italy’s most cited biomedical scientists with an h-index of 46. His innovative work includes developing models for chaotic modulation in redox biology and proposing the concept of Shannon dissipation as a thermodynamic foundation for life. Dr. Chirumbolo has extensive editorial experience, serving on the boards of renowned journals including Scientific Reports, International Immunopharmacology, and Molecules. He actively collaborates with international institutions across Europe and promotes integrative, transdisciplinary biomedical approaches. His dedication to biophysical complexity and system-based innovation continues to influence translational medicine, making him an ideal nominee for the Research for Innovative Research Award.

Publication Profile:

Google Scholar

Scopus

✅ Strengths for the Award:

  1. Innovative Scientific Contributions:
    Dr. Chirumbolo’s concept of Shannon dissipation as the thermodynamic foundation of life represents a paradigm shift in theoretical biology. His model bridges information theory with biogenesis, advancing the frontiers of systems immunology and biological epistemology.

  2. Translational Research in Ozone Therapy:
    His chaotic modulation model for medical ozone effects introduces a systems-level interpretation of therapeutic mechanisms, with significant implications for redox biology, regenerative medicine, and inflammation management.

  3. Prolific Academic Output:
    With over 400 publications indexed in Scopus and Google Scholar, and an h-index of 46, Dr. Chirumbolo demonstrates sustained academic productivity, peer recognition, and impact in biomedical sciences.

  4. Editorial and Leadership Roles:
    He is actively involved with high-impact journals including Scientific Reports (Nature portfolio), International Immunopharmacology, and Molecules, contributing to global scientific discourse.

  5. Global Collaborations:
    His affiliations with institutions in Norway, Ukraine, Romania, Poland, and Italy reflect his commitment to cross-border scientific exchange and integrative research efforts.

🔧 Areas for Improvement:

  1. Patent and Industry Translation:
    Despite deep theoretical and experimental knowledge, Dr. Chirumbolo’s portfolio currently lacks patents or industrial consultancy projects. Advancing translational aspects of his models into commercial or clinical applications would enhance real-world impact.

  2. Public Communication and Outreach:
    While academically prolific, wider dissemination of his findings to non-specialist or policy-making audiences could increase societal relevance and interdisciplinary uptake.

🎓 Education:

Dr. Chirumbolo earned his Medical Specialization in Biochemical Chemistry in 1995, marking the beginning of his journey in biomedical sciences. His academic roots are grounded in clinical biochemistry, molecular biology, and translational medicine. He trained in Italy’s National Health System, where he directed various molecular biology laboratories, gaining firsthand experience in diagnostic innovation and experimental biochemistry. With a strong foundation in cellular and molecular biology, his educational path laid the groundwork for his systems-level understanding of biological complexity. His commitment to continuous learning is evident in his interdisciplinary research spanning immunology, redox biology, information theory, and ozone therapy. He is actively engaged in scientific discourse through editorial appointments and international conferences, nurturing the next generation of systems biologists and medical scientists. His academic lineage blends traditional biochemical education with pioneering insights into biological epistemology and complex systems science.

🧪 Experience:

Dr. Chirumbolo has over three decades of professional experience in biochemistry, molecular biology, and translational research. Starting in Italy’s National Health System, he directed molecular labs focusing on clinical diagnostics and immunological assays. He later transitioned to academia, becoming a Senior Researcher at the University of Verona. He has led major research initiatives involving oxidative stress, basophil biology, and the use of phytochemicals in chronic diseases. As an editor for journals like Scientific Reports, International Immunopharmacology, and Molecules, he has shaped international scientific dialogue. His collaborations span Italy, Norway, Ukraine, Romania, and Poland, involving diverse domains such as chemical biology and clinical immunology. He also contributes to bioinformatic modeling of redox systems and life origin theories. With over 400 indexed publications, Dr. Chirumbolo’s multidisciplinary expertise bridges clinical and theoretical biosciences, driving innovative solutions in modern medicine.

🔬 Research Focus:

Dr. Chirumbolo’s research focuses on biomedical systems, oxidative stress, and the thermodynamic foundations of life. He developed the novel concept of Shannon dissipation, linking informational entropy to the emergence of biological life, aligning with thinkers like Varela and Maturana. His work in ozone therapy led to the formulation of chaotic modulation models that explain its redox-based medical efficacy. He also investigates bioinformatic modeling, basophil signaling, phytochemical impacts, and nutraceutical interventions in chronic inflammation, allergy, and metabolic disorders. His models propose mechanistic insights into cell signaling and antioxidant networks, enhancing therapeutic targeting. Recent contributions include exploring the microvascular effects of SARS-CoV-2, the interface of redox dynamics and cellular adaptation, and ozone’s systemic regulatory properties. Through extensive collaborations, he integrates cellular, chemical, and systems-level research to push the boundaries of personalized and integrative medicine.

📚 Publications Top Notes:

  • 🧪 Ozone therapy addresses neuropathic pain in ulcerous wounds

  • 🍊 Something more about the role of flavonoids in aging

  • 🩸 Prolonged alterations in red blood cell rheology following mild SARS-CoV-2 infection: Implications for microvascular health

  • 💉 Intravenous glutathione should not be mismatched with ozone as an antioxidant therapy

  • 🌬️ Sonic transdermal transfer of ozone and its use in oxygen-ozone therapy. Wheat and chaff

  • 🧬 Effect of SARS-CoV2 S protein on red blood cells parameters. Some comments

  • ⚠️ Adverse effects following some practices of ozone therapy for disc herniation. Critical comments

  • 🧠 Post-infective myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and post-COVID as two puzzling faces of the same medal

  • 🦴 Synovial Fluid as a Crucial Component of the Joint Microenvironment in Rheumatoid Arthritis

  • ❤️ Aetiology and clinical manifestations of patients with non-dilated left ventricular cardiomyopathy. Some comments

🧾 Conclusion:

Dr. Salvatore Chirumbolo is highly suited for the Research for Innovative Research Award. His work exemplifies pioneering thought, multidisciplinary integration, and scientific originality. From foundational biological theory to clinically relevant applications like ozone therapy and oxidative stress modulation, his contributions address both the “why” and “how” of living systems. His influence is evident in his citation record, editorial appointments, and leadership in cutting-edge biomedical modeling.

 

Yang Liu | Cell Migration Studies | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Yang Liu | Cell Migration Studies | Best Researcher Award

Prof. Dr. Yang Liu, Taiyuan University of Technology Institute of Biomedical Engineering CHINA, China

Dr. Yang Liu is an Associate Professor at the Institute of Biomedical Engineering, Taiyuan University of Technology, China. Since joining in 2013, Dr. Liu has focused on biomechanics, particularly the mechanical mechanisms involved in skin tissue damage and healing processes during traumatic events like burns and radiotherapy. Her interdisciplinary work bridges molecular, cellular, and tissue-level studies to better understand the interplay between mechanical factors and skin regeneration. Her research also extends into the development and structural optimization of biomedical materials such as tissue-engineered skins and advanced dressings. Dr. Liu has led several research and teaching reform projects, obtained a patent transformation, and contributed to national and provincial-level scientific investigations. Her innovative work in tissue engineering and skin trauma treatment continues to contribute significantly to biomedical science and material engineering.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Specialized Expertise
    Dr. Liu focuses on biomechanics in disease development, particularly related to cutaneous trauma (e.g., burns, radiotherapy), a niche but critical area in biomedical engineering.

  2. Material Innovation
    Her work in developing tissue-engineered skin and antibacterial dressings demonstrates applied innovation with potential clinical relevance.

  3. Project Leadership
    Successfully led and participated in multiple competitive research projects funded by national and provincial bodies, indicating trust in her scientific vision and capabilities.

  4. Research Productivity
    Though early in recognition, Dr. Liu has already co-authored several peer-reviewed journal articles in reputable publications like Scientific Reports and Placenta, which reflect growing academic contribution.

  5. Translational Research
    Her involvement in a patent achievement transformation shows a commitment to moving research beyond the lab into real-world applications.

🔧 Areas for Improvement:

  1. Citation Impact and Indexing
    The provided articles currently have 0 citations, and there is no citation index or h-index reported. Increasing publication visibility and citation impact should be a future focus.

  2. Global Recognition and Collaboration
    There is no mention of international collaboration, editorial roles, or professional memberships, which would enhance credibility and reach.

  3. Documented Industry Linkages
    Despite some project engagement with enterprises, more evidence of sustained industry partnerships or commercialization success would strengthen the application.

  4. Books, Patents, and Conferences
    Absence of published books, patents in process, or keynote roles in international conferences limits the academic portfolio breadth.

🎓 Education:

Although specific degree details are not listed, Dr. Yang Liu has built a strong academic foundation that supports her expertise in biomedical engineering and biomechanics. Her academic journey is closely aligned with her professional role at Taiyuan University of Technology, which is known for its technical research capabilities. Dr. Liu’s knowledge spans skin tissue biology, mechanical trauma, and biomedical materials science, indicating a background that likely includes degrees in biomedical engineering, bioengineering, or a related field. Her educational experience has equipped her with the skills necessary to conduct high-level research in skin regeneration, materials science, and tissue biomechanics. Additionally, her active participation in national scientific projects and her leadership in academic innovation at the university level point to rigorous formal training and ongoing academic development.

🧪 Experience:

Dr. Yang Liu has over a decade of professional experience in biomedical research since joining the Taiyuan University of Technology in 2013. Her work has revolved around exploring the mechanical and biological factors involved in traumatic skin injury and healing. She has successfully led and contributed to multiple projects, including those funded by the National Natural Science Foundation of China and enterprise collaborations. In addition to her scientific contributions, she has also directed teaching reform projects and a patent transformation, highlighting her dual commitment to both research and education. Her experience includes a strong focus on interdisciplinary collaboration across biology, materials science, and mechanical engineering. This breadth of experience has allowed her to develop innovative biomedical materials, such as tissue-engineered skin and functional skin dressings, aimed at improving clinical treatment outcomes for burn injuries and other trauma-related skin conditions.

🔬 Research Focus:

Dr. Yang Liu’s research centers on the biomechanics of skin tissue damage and healing, with an emphasis on cutaneous trauma from burns and radiotherapy. Her work investigates how mechanical forces impact skin at multiple biological levels—molecular, cellular, tissue, and animal models. A major portion of her research explores biomedical material innovation, particularly tissue-engineered skin, skin dressings, and antibacterial materials. She is particularly focused on understanding how structural and mechanical properties of these materials can improve therapeutic outcomes. Dr. Liu also studies oxidative stress, cell migration, and protein responses under mechanical pressure, making her work crucial to trauma therapy and regenerative medicine. With a patent transformation and multiple research projects to her credit, her research is positioned at the intersection of engineering innovation and clinical application, aiming to reduce complications in skin trauma treatment and enhance recovery efficiency through scientifically engineered materials.

📚 Publications Top Notes:

  1. 🧴🧬 Preparation and characterization of nano-silver/graphene oxide antibacterial skin dressing – Scientific Reports, 2025

  2. 🔬⛽ Experimental study on liquid products and pore structure characteristics of anthracite saturated by supercritical CO₂ – Gas Science and Engineering, 2025

  3. 🧠💥 The regulatory role of the nuclear scaffold protein Emerin on the migration of amniotic epithelial cells and oxidative stress in a pressure environment – Placenta, 2025

  4. 🛠️🔥 Annealing Response of Cold-rolled Ti₂AlNb Based Alloy Foil in Different Phase Regions – Tezhong Zhuzao Ji Youse Hejin (Special Casting and Nonferrous Alloys), 2025

📝 Conclusion:

Dr. Yang Liu shows significant promise as a biomedical researcher, with a clear, focused research trajectory, practical outputs (materials for skin regeneration), and consistent project engagement at institutional and national levels. While her global visibility and citation metrics are currently limited, her research has high translational potential in trauma medicine and biomedical materials, making her a strong emerging contender for the Best Researcher Award—especially under a category recognizing early- to mid-career researchers with impactful applied science work.

Philippe Menasché | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Prof. Philippe Menasché | Stem Cell Research | Best Researcher Award

Prof. Philippe Menasché, AP-HP, France

Prof. Philippe Menasché, born on August 10, 1950, is a pioneering French cardiovascular surgeon and regenerative medicine researcher. Renowned globally for his work in cell therapy and heart failure, he performed the world’s first fetal stem cell transplantation in a human heart. With over four decades in medicine, he has blended surgical excellence with translational research, bridging the gap between bench and bedside. A professor since 1988, his leadership spans multiple roles—from senior hospital surgeon to director of major research teams at INSERM and the Carpentier Foundation. He has served as scientific advisor to health authorities and remains an active contributor to high-impact publications and international collaborations. A recipient of prestigious honors such as the Prix Galien and the Earl Bakken Award, Prof. Menasché continues to shape the future of cardiovascular regenerative therapy.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Pioneering Clinical Innovation

    • Performed the first-in-man fetal stem cell transplantation for cardiac repair.

    • Led translational research turning basic stem cell science into clinical applications.

  2. Extensive Academic and Research Leadership

    • Over four decades of experience as a cardiovascular surgeon and academic leader.

    • Directed major units at INSERM, Carpentier Foundation, and Paris Hospitals.

  3. Global Recognition and Awards

    • Recipient of highly prestigious scientific prizes such as the Prix Galien (2016) and Earl Bakken Award (2011).

    • Recognized by top French and international medical societies.

  4. Recent and Relevant Research Impact

    • Active contributor to multicenter trials including ISCHEMIA, STROMA-CoV-2, and TRAUMACELL.

    • Publications in high-impact journals on cardiac regeneration, cell therapy, and stem cell-derived secretomes.

  5. Leadership in Science Policy and Ethics

    • President of the Medical and Scientific Council at France’s Agency of Biomedicine.

    • Advisor to the French Minister of Health (2005–2007), influencing national bioethics and translational policy.

⚠️ Areas for Improvement:

  1. Broader International Integration

    • While internationally recognized, deeper ongoing collaboration with North American and Asian biomedical consortia could further elevate global influence.

    • The upcoming visiting professorship at Columbia University (2025) is a strong step in this direction.

  2. Integration of AI & Digital Health

    • Limited evidence of work in AI-guided regenerative medicine, machine learning in cardiac diagnostics, or digital health integration in therapeutic development.

    • These areas represent major future growth potential in cardiac care.

  3. Mentorship Visibility

    • While his scientific contributions are vast, greater emphasis on training and mentoring the next generation of clinician-scientists would bolster his legacy.

📚 Education:

Prof. Menasché’s academic foundation is rooted in two pillars of French higher education. He earned his Doctor of Medicine (MD) from the Faculté de Médecine de Paris in 1979, graduating with honors, including the coveted Internship Golden Medal. He then pursued deeper inquiry into biomedical science, culminating in a Doctorate in Science (PhD) from Université Paris-Orsay in 1987. His dual training in clinical medicine and scientific research provided the ideal springboard for a career that integrates patient care with innovation. In 1988, he became a Professor of Thoracic and Cardiovascular Surgery, reflecting his command of both technical skill and academic leadership. His scholarly progression has also led to visiting roles abroad, including a forthcoming appointment as Visiting Professor in Biomedical Engineering at Columbia University in 2025. This cross-disciplinary education empowers his unique contribution to both surgical practice and regenerative cardiovascular therapies.

🏥 Experience:

Prof. Menasché began his medical journey in 1973 as an intern in Paris hospitals, ascending to Senior Staff Surgeon in 1988—a position he still holds. From 1995 to 2007, he served as Director of Research at the Surgical School of the Greater Paris Academic Hospitals. His research leadership extended to INSERM, where he directed Unit U633 and co-led regenerative therapy teams. He headed the Laboratory of Biosurgical Research at the Carpentier Foundation from 2002 to 2018. In parallel, he has played influential roles on regulatory and advisory boards, including as President of the Medical and Scientific Council of France’s Agency of Biomedicine. A dedicated member of multiple medical and scientific societies, Prof. Menasché has edited prestigious journals and contributed to over a dozen major clinical trials and collaborative studies. His experience combines clinical excellence, institutional leadership, and innovative research in heart failure and cell therapy.

🧬 Research Focus:

Prof. Menasché’s research is centered on regenerative medicine for cardiovascular diseases, particularly using stem cells and secretomes to repair damaged heart tissue post-myocardial infarction. His team explores therapeutic strategies involving pluripotent stem cell-derived cardiomyocytes, mesenchymal stromal cells, and extracellular vesicles to promote myocardial regeneration and immune modulation. He has led pioneering first-in-human trials, including the use of cell-derived secretomes in heart failure patients. His investigations bridge fundamental science with translational application, often conducted in multicenter randomized controlled trials. His work also intersects with neurological conditions, such as traumatic brain injury, using cell-based therapies to address neuroinflammation. Prof. Menasché is also involved in evaluating the safety and efficacy of stem cell-based interventions in ARDS, including COVID-19-associated cases. A central member of the European Society of Cardiology’s regenerative medicine group, he is advancing personalized and precise treatments for heart failure through novel biologics and bioengineering tools.

📄 Publications Top Notes:

  1. 🫀 Revitalizing the heart: strategies and tools for cardiomyocyte regeneration post-myocardial infarction

  2. 💉 Trials and tribulations of cell therapy for heart failure: an update on ongoing trials

  3. 🫀📊 Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial

  4. 🧠🧪 Effects of intravascular administration of mesenchymal stromal cells…after traumatic brain injury (TRAUMACELL)

  5. 💓🧫 Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial

  6. 🦠🫁 Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells (STROMA-CoV-2)

  7. 🧬💗 Head-to-head comparison of relevant cell sources of small extracellular vesicles for cardiac repair

  8. 🫀💉 First-in-man use of a cardiovascular cell-derived secretome in heart failure – Case report

  9. 🧬🫀 Human PSC-derived cardiac cells and their products: therapies for cardiac repair

  10. 🫀🫄 Impact of Complete Revascularization in the ISCHEMIA Trial

📝 Conclusion:

Prof. Philippe Menasché is exceptionally qualified for the Best Researcher Award. His groundbreaking work in cardiac regeneration, commitment to translational medicine, and lasting contributions to surgical science and healthcare policy make him a uniquely impactful figure. His track record is not only defined by scientific innovation but also by societal relevance, particularly in addressing heart failure—a leading global health burden.

Guojie Ji | Cancer Cell Biology | Cancer Cell Biology Award

Published on by Cell Biologist

Mr. Guojie Ji | Cancer Cell Biology | Cancer Cell Biology Award

Mr. Guojie Ji, NORTH HENAN MEDICAL UNIVERSITY, China

Guojie Ji, Master of Medicine Science, is a laboratory technician and the Provincial Director of the Demonstration Center for Biological and Basic Medical Experimental Teaching. With a core research focus on fertility preservation and tumor therapy, he brings an interdisciplinary approach to biomedical science. Ji has played a pivotal role in guiding over 30 research papers and acquiring 13 national patents. In addition to managing over 15 national and provincial projects, his mentorship has led students to win numerous innovation and entrepreneurship awards at both national and provincial levels. Ji is an editorial board member for Contemporary Chemical Research and a peer reviewer for Cell Death Discovery. His leadership and scholarly work have earned him several honors, including being named Outstanding Teacher and Provincial Outstanding Mentor. His recent research delves into ferroptosis in cancer and reproductive toxicity, making impactful contributions to both cancer biology and regenerative medicine.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Relevant Research Contributions:

    • Ji has made direct contributions to cancer biology, particularly through:

      • Ferroptosis mechanisms in breast cancer cells (2025, BBRC)

      • 5-Fluorouracil-induced oxidative damage and DNA disruption (2024, Ecotoxicology & Environmental Safety)

      • Exosome impact on melanoma cell growth (2021, Journal of Yangzhou University)

    • These studies reflect deep involvement in molecular mechanisms of cancer cell death, a central theme in cancer cell biology.

  2. Multidisciplinary Integration:

    • Ji’s research spans stem cells, oxidative stress, and reproductive toxicity, all of which tie into cancer research—especially in terms of chemotherapy side effects and regenerative implications.

  3. High Research Output and Recognition:

    • Over 30 peer-reviewed articles, including in high-impact journals such as Cell Death Discovery and BBRC.

    • 13 national patents, indicating applied innovation in biomedical research.

    • Leads national and provincial projects with substantial funding (~¥1 million), showcasing leadership and research management.

  4. Mentorship and Scientific Community Service:

    • Recognized as an Outstanding Innovation Mentor, Editorial Board Member, and Peer Reviewer, reflecting active participation in advancing the field.

    • Mentored award-winning student teams in national competitions, indicating talent cultivation in biomedical research.

⚠️ Areas for Improvement:

  1. Primary Focus Is Fertility & Reproductive Biology:

    • While Ji has notable cancer-related studies, his primary research base lies in fertility preservation. For this award, a broader and more central focus on oncogenic signaling, tumor microenvironments, or immunotherapy might strengthen his profile.

  2. Limited Clinical Cancer Studies:

    • Most cancer work is preclinical or in vitro; integrating clinical collaborations or translational oncology trials could enhance relevance to applied cancer therapy.

Education:

Guojie Ji holds a Master of Medicine Science, with specialized training in biological sciences, biomedical research, and clinical applications in fertility and tumor biology. His academic background includes comprehensive training in cell biology, molecular biology, reproductive medicine, and translational oncology. Through this foundation, he developed a research orientation focused on bridging cell-level discoveries with clinical potential, particularly in the areas of cryopreservation, stem cell differentiation, and tumor cell regulation. Ji’s academic excellence and commitment to research have driven his involvement in interdisciplinary fields, where he combines elements of life sciences and therapeutic innovation. His deep-rooted academic experiences have been critical in enabling his success as a project leader, educator, and recognized biomedical scientist. His education is not just academic but applied, demonstrated by his integration of research into experimental teaching models and training future life scientists.

💼 Experience:

Guojie Ji currently serves as a Laboratory Technician and Provincial Director for a Demonstration Center dedicated to experimental biological and medical teaching. He has led or completed 10+ major national and provincial research projects, along with 5 horizontal interdisciplinary research collaborations, collectively funded with nearly 1 million yuan. Ji’s lab has been instrumental in developing fertility-preservation protocols, studying sperm cryopreservation, and examining cancer cell response to drugs like 5-FU. He has authored over 30 peer-reviewed papers, including key publications in Cell Death Discovery, Ecotoxicology and Environmental Safety, and Biochemical and Biophysical Research Communications. Ji is a mentor to undergraduate innovators, guiding teams to national victories in prestigious competitions. Additionally, he holds editorial and peer-review roles in prominent scientific journals. His work demonstrates strong leadership, scholarly innovation, and an enduring commitment to experimental medical education and biomedical research.

🏆 Awards and Honors:

Guojie Ji’s contributions to research and education have earned him widespread recognition. He has been honored as a Key Teacher, Civilized Teacher, and Outstanding Teacher, along with awards for Outstanding Innovation and Entrepreneurship Mentorship at the provincial level. He has received accolades as Outstanding Supervisor for Bachelor’s Degree Dissertations and Life Sciences Competition Mentor. Ji has successfully supervised student teams winning over 25 awards, including 5 national-level prizes in events such as the Challenge Cup, Internet+, and the National College Life Sciences Competition. These honors reflect his commitment to combining cutting-edge research with student training and public impact. His ability to mentor and lead both in the lab and the classroom has set a benchmark for excellence in academic innovation and practical scientific development. Ji’s holistic excellence makes him a role model in both research mentorship and scientific discovery.

🔬 Research Focus:

Guojie Ji’s research lies at the intersection of fertility preservation, cryobiology, and tumor cell biology. He explores the mechanisms of cell damage, oxidative stress, and DNA integrity during sperm and stem cell preservation, with a growing emphasis on ferroptosis—a regulated form of cell death—in cancer biology. His recent studies demonstrate how agents like 5-Fluorouracil affect cancer cells and male fertility via oxidative and mitochondrial pathways. Ji also investigates mesenchymal stem cell-derived exosomes in tumor growth, highlighting a promising field of cell-free therapies. In plant and animal models, he’s contributed to understanding protein and lipid roles in cell signaling and disease resistance, reinforcing the depth and range of his biomedical expertise. With a diverse research portfolio, Ji aims to translate basic discoveries into therapeutic strategies, particularly targeting tumor suppression and reproductive health. His work continues to expand the molecular understanding of cell survival and death pathways in medicine.

📚 Publications Top Notes:

  1. 🧊 Protective Effect of Sucrose and Antioxidants on Cryopreservation of Sperm Motility and DNA Integrity in C57BL/6 Mice

  2. 💧 Effects of MTG and GSH on Human Sperm Motility and DNA Integrity during Vitrification in the Presence of Trehalose

  3. ❄️ Comparison of Rapid Freezing vs. Vitrification for Human Sperm Cryopreservation Using Sucrose in Closed Straw Systems

  4. 🔍 Studies on Basic Issues Relevant to Sperm Cryopreservation in Humans

  5. 📦 Effects of Exosomes Derived from Mesenchymal Stem Cells on the Growth of Melanoma Cells

  6. 🌱 BMP4 is Insufficient to Differentiate Umbilical Cord MSCs into Germ Cell-like Cells In Vitro

  7. 🧬 Current Status of Male Fertility Preservation in Humans

  8. 🧪 Protein Glycosylation Changes During Systemic Acquired Resistance in Arabidopsis thaliana

  9. 🛡️ Lipid Transfer Proteins in Plant-Pathogen Interactions and Their Molecular Mechanisms

  10. 🔥 Emerging Roles of Ferroptosis in Male Reproductive Diseases

🧾 Conclusion:

Guojie Ji is a strong interdisciplinary researcher with a credible and impactful body of work in cancer cell biology, particularly in the context of ferroptosis, chemotherapy-induced toxicity, and tumor suppression mechanisms. His contributions bridge the fields of cell death, oxidative biology, and reproductive toxicology, offering unique insights into the systemic effects of anti-cancer agents. While cancer is not his sole research domain, his innovative work and translational potential clearly qualify him as a compelling nominee for the Research for Cancer Cell Biology Award—particularly in molecular cancer mechanisms and therapeutic research.